Annual General Meeting 2015

Tecan shareholders endorse all motions proposed by the Board of Directors

Tecan Group AG / Annual General Meeting 2015: Tecan shareholders endorse all motions proposed by the Board of Directors . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

• Dividend of CHF 1.50 per share
• Rolf Classon, Heinrich Fischer, Oliver Fetzer, Karen Huebscher, Christa Kreuzburg and Gérard Vaillant re-elected as members of the Board of Directors
• Lars Holmqvist elected as a new member of the Board of Directors
• Rolf Classon confirmed by shareholders as Chairman of the Board
• Oliver Fetzer and Christa Kreuzburg confirmed as members of the Compensation Committee
• All proposals relating to compensation approved

Männedorf, Switzerland, April 16, 2015 - The Annual General Meeting of Tecan Group Ltd. (SIX Swiss Exchange: TECN) has today endorsed all motions proposed by the Board of Directors. Shareholders approved the Annual Report, the financial statements and the consolidated financial statements, and granted discharge to the Board of Directors and the Management Board. They also approved a dividend of CHF 1.50 per registered share, unchanged versus the previous year. The payout will take place on April 22, 2015.

All members of the Tecan Board of Directors who stood for re-election were confirmed by the shareholders for a term of one year: Heinrich Fischer, Dr. Oliver Fetzer, Dr. Karen Huebscher, Dr. Christa Kreuzburg, Gérard Vaillant and Rolf Classon. Rolf Classon was re-elected as Chairman of the Board of Directors. The shareholders also confirmed Oliver Fetzer and Christa Kreuzburg as members of the Compensation Committee.

The Annual General Meeting elected Lars Holmqvist as a new member of the Board of Directors. Lars Holmqvist, 56, a Swedish national, brings more than 25 years' international experience within the medical device, pharmaceutical and life science industries, where he held roles in marketing, sales and business management. Most recently, he was President of the Life Sciences and Diagnostics Group and Senior Vice President at Agilent Technologies Inc.